acarix

English, Interim, IR, MAR, News, Q3, Regulatory, Report

November 18, 2024

16 Nov 2022

Full focus on the US market with strong interest from healthcare providers, reimbursement code in place and collaboration with ACC

Acarix is now taking an important strategic step, putting full commercial focus on the US market. We have the key building blocks in pl...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

15 Nov 2022

Invitation to presentation of Acarix´s third quarter report 2022

Acarix will publish its third quarter results on Wednesday 16 November 2022 at 08.00 am (CEST). A live webcast will be held at 16.30 (C...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

28 Sep 2022

Patient enrollment completed in the FILTER-SCAD randomized controlled multi-center trial

The FILTER-SCAD study is a randomized controlled clinical trial including more than 2,000 patients with suspected coronary artery disea...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

26 Sep 2022

Acarix and the American College of Cardiology announce strategic collaboration

The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to deve...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

22 Sep 2022

Acarix presents at the Redeye event, Theme: Diagnostics

On September 27 at 11.30 am CEST, Helen Ljungdahl Round, President and CEO at Acarix will present the company´s latest developmen...

Continue reading

acarix

English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report

November 18, 2024

25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

22 Aug 2022

Invitation to presentation of Acarix´s second quarter report

Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

22 Jun 2022

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska

Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®Syst...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

10 Jun 2022

Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana.

Press release Malmö, Sweden, June 10, 2022   Acarix signs additional commercial agreement in US and receives order...

Continue reading

acarix

Corporate Information, English, IR, News, Order, Sales

November 18, 2024

03 Jun 2022

Acarix signs additional commercial agreement in US and receives rapid orders in both Mississippi and Tennessee

Press release Malmö, Sweden, June 3, 2022   Acarix signs additional commercial agreement in US and receives rapid...

Continue reading

acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM

November 18, 2024

11 May 2022

Announcement from Acarix’s annual general meeting

Press release Malmö, Sweden, May 11, 2022   Announcement from Acarix's annual general meeting The annual general ...

Continue reading

acarix

English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report

November 18, 2024

11 May 2022

Acarix AB (publ) publishes Interim Report, January – March 2022

Press release Malmö, Sweden, May 11, 2022   Acarix AB (publ) publishes Interim Report, January – March 2022 ...

Continue reading